MākuSafe Profiled in Novarica Report on InsurTech Landscape
September 15, 2020
InsureTech Startup Market Continues to Grow, with Increased Focus on Customer Experience and Rapid Time-to-Value for Insurer Partners According to Novarica.
Novarica’s annual report profiles 250 InsureTechs with a focus on opportunities to partner, learn, and create value.
With time horizons shortened to reflect uncertainty about the future, insurance carriers investing in or partnering with InsureTech startups appear to be focusing on tactical initiatives that can produce more immediate results than some of the more speculative R&D efforts more common in the pre-pandemic era. In its fourth annual report, InsureTech for Insurers: 250 Startup Profiles, research and advisory firm Novarica outlines the InsureTech landscape for insurers, focusing on two key questions: Does this matter to my company? And what can we learn from it?
“One lesson that emerges from the 250 InsureTech startups Novarica has profiled in this report is that the insurance industry should rethink its consumer experience from every angle,” said Jeff Goldberg, Executive Vice President of Research and Consulting and co-author of Novarica’s new report. “Across all lines of business and across all sizes, insurers will feel the impact as InsureTech startups shift customer expectations and point the way for more effective, insightful operations.”
Among the key findings of the report are:
- AI messaging is everywhere. Everyone’s talking about AI, but real AI is less clear. Even so, adoption of AI technologies like machine vision and natural language processing is growing across lines of business and use cases.
- Insurance is going beyond direct online. Many startups are rethinking distribution, bringing products to consumers rather than simply enabling a direct online purchase.
- Startups previously positioned as competitors are becoming partners. Many startup “carriers” are licensing their platforms to allow insurers to develop niche products and branch into new lines of business, though the effectiveness of this pivot is yet to be proven.
